Urology Radiology Cardiology A
Contrast Nephropathy Risk Score
Mehran risk score for contrast-induced acute kidney injury (CI-AKI) after contrast exposure.
References
- Mehran R, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol. 2004;44(7):1393-1399.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- N-Acetylcysteine (Contrast Nephropathy) · Contrast-Induced Nephropathy Prevention
- Amoxicillin (Otitis Media / Sinusitis) · Beta-lactam antibiotic
- Palivizumab · RSV Prophylaxis — Monthly Monoclonal Antibody (High-Risk Infants)
- Sucralfate (Burns — GI Mucosal Protection) · Cytoprotective Agent — GI Mucosal Protection
- Ziprasidone · Atypical Antipsychotic — D2/5-HT2A Antagonist (Low Metabolic Risk)
- Vancomycin (Renal Dosing) · Antibiotic Dosing in CKD
Pathways
- Acute Pyelonephritis · NICE; BAUS; RCOG — CG109, NG109
- Haematuria Assessment · NICE NG12 / BAUS 2020
- Acute Urinary Retention · EAU 2022 / NICE BPH
- Renal Colic and Ureteric Stones · EAU 2023 / NICE CG160
- Prostate Cancer Diagnosis · NICE NG131 2019
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.